Profits double to nearly €15m for pharma firm
Accounts just filed by the US-owned Bioniche Pharma Holdings Ltd and subsidiaries to the Companies Office show that the group increased its revenues by 136% from €40m to €94.6m in the 12 months to the end of June 30, 2010.
The group manufactures and distributes speciality pharmaceutical injectables in vials and syringes, mainly in Europe and the US, to cover a wide range of treatments — anaesthetics, orthopedics, oncology and urology.
			    
                    
                    
                    
 
 
 
 
 
 


          

